HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

C J Harrison Selected Research

C J Harrison Research Topics

Disease

4Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia)
12/2010 - 02/2000
4Infections
10/2009 - 02/2000
2Precursor T-Cell Lymphoblastic Leukemia-Lymphoma (T-ALL)
01/2018 - 02/2000
2Herpes Genitalis (Genital Herpes)
03/2002 - 03/2001
2Otitis Media
11/2001 - 10/2001
2Chromosome Aberrations (Chromosome Abnormalities)
09/2001 - 09/2000
1Melanoma (Melanoma, Malignant)
03/2022
1Leukemia
01/2017
1Breast Neoplasms (Breast Cancer)
09/2015
1Cardiotoxicity
12/2005
1Multiple Myeloma
09/2005
1Pathologic Complete Response
01/2004
1Warts (Wart)
03/2002
1Virus Diseases (Viral Diseases)
03/2002
1Otitis
11/2001
1Cytomegalovirus Infections (Inclusion Disease)
06/2001
1Exanthema (Rash)
01/2001
1Diarrhea
01/2001
1Fever (Fevers)
01/2001
1Appendicitis
01/2001
1Down Syndrome (Down's Syndrome)
02/2000
1Human Influenza (Influenza)
01/2000

Drug/Important Bio-Agent (IBA)

4Anti-Bacterial Agents (Antibiotics)IBA
01/2004 - 01/2001
3Imiquimod (Aldara)FDA LinkGeneric
03/2002 - 02/2001
2Proteins (Proteins, Gene)FDA Link
01/2018 - 09/2015
2Glycoproteins (Glycoprotein)IBA
06/2001 - 02/2001
2Antiviral Agents (Antivirals)IBA
03/2001 - 01/2000
1ProteomeIBA
01/2018
11- cyclopropyl- 3- (3- (5- morpholin- 4- ylmethyl- 1H- benzoimidazol- 2- yl)- 1H- pyrazol- 4- yl)ureaIBA
01/2017
1Aurora KinasesIBA
01/2017
1Transcription Factors (Transcription Factor)IBA
09/2015
1Virulence Factors (Pathogenicity Factors)IBA
10/2009
1Cytarabine (Cytosar-U)FDA LinkGeneric
12/2005
1AnthracyclinesIBA
12/2005
1Immunoglobulin Heavy Chains (Immunoglobulin Heavy Chain)IBA
09/2005
1Amoxicillin (Wymox)FDA LinkGeneric
11/2001
1Clavulanic Acid (Potassium Clavulanate)FDA LinkGeneric
11/2001
1Penicillins (Penicillin)FDA Link
10/2001
1resiquimodIBA
03/2001
1VaccinesIBA
02/2001
1Meropenem (Merrem)FDA LinkGeneric
01/2001
1Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
02/2000
1Dacarbazine (DIC)FDA LinkGeneric
02/2000

Therapy/Procedure

5Therapeutics
01/2004 - 09/2000
1Radiotherapy
03/2022
1Aftercare (After-Treatment)
03/2022
1Ligation
12/2010
1Immunomodulation
03/2002
1Antibiotic Prophylaxis
10/2001
1Chemoprevention
10/2001